Follow ASTCT®
The following promotional activities are provided by sponsors and are not certified for continuing education credit. The content of these events and opinions expressed by presenters are those of the sponsor or presenters and not of the Tandem Meetings, ASTCT or CIBMTR.
All of the Product & Innovation Theater events will take place in Exhibit Hall.
Featured
Non-Featured
Making the Case for Early Use of CAR-T Therapy in Multiple Myeloma
Location TBD
This promotional activity is provided by Johnson & Johnson and Legend Biotech, and is not certified for continuing education credit.
A Treatment Option for Adults with Certain R/R DLBCL After ≥ 2 Prior Lines of Systemic Therapy
Location TBD
This promotional activity is provided by Pfizer and is not certified for continuing education credit.
Engineering Better Inputs: How Data Improves Car-T Starting Material
Location TBD
This promotional activity is provided by Terumo Blood and Cell Technologies and is not certified for continuing education credit.
Advancing CAR T Therapy: GPRC5D as the Next Frontier in Relapsed/Refactory Multiple Myeloma
Location TBD
This promotional activity is provided by Bristol Myers Squibb and is not certified for continuing education credit.
Recent Developments in Optimization and Personalization of TCRαβ/CD19 Depleted Transplantation
Location TBD
This promotional activity is provided by Miltenyi Biomed and is not certified for continuing education credit.
Pathogen Reduced Platelets: The Silent Guardian for Stem Cell Transplant Recipients
Location TBD
This promotional activity is provided by Cerus Corporation and is not certified for continuing education credit.
Advancing Care in RRMM: Clinical Evidence for a BCMA-Directed Bispecific Antibody Treatment Option
Location TBD
This promotional activity is provided by Pfizer and is not certified for continuing education credit.
Diagnosing and Treating TA-TMA with Newly Approved Narsoplimab-wuug
Location TBD
This promotional activity is provided by Omeros Corporation and is not certified for continuing education credit.
MONJUVI: Advancing Patient Care in 2L+ Follicular Lymphoma and R/R Diffuse Large B-Cell Lymphoma
Location TBD
This promotional activity is provided by Incyte Corporation and is not certified for continuing education credit.
Exploring new directions: Remestemcel-L-rknd added to ruxolitinib as initial treatment for steroid refractory acute GVHD (CTN2303): A phase III placebo-controlled study developed by Mesoblast and the BMT Clinical Trials Network.
Location TBD
This promotional activity is provided by Synapse, the Marketing Company for Mesoblast and is not certified for continuing education credit.
Expanding Access to Allo-HT in Severe Aplastic Anemia (SAA) with a New Cell Therapy Option: Addressing Patient and Clinical Perspectives
Location TBD
This promotional activity is provided by Gamida Cell and is not certified for continuing education credit.
Operational Considerations in Expanding CAR-T Use: From Satellite Apheresis to Outpatient and Everything in Between
Location TBD
This promotional activity is provided by Johnson & Johnson and is not certified for continuing education credit.
CAR T Vision: Working together to double the proportion of eligible patients treated with CAR T by 2030
Location TBD
This promotional activity is provided by Incisive Health and is not certified for continuing education credit.
Two Distinct Pathways, One Shared Goal: A Nonoverlapping, Sequential Approach to Target Inflammation and Fibrosis in cGVH
Location TBD
This promotional activity is provided by Incyte Corporation and is not certified for continuing education credit.
From Eligibility to Access: An Honest Conversation on Navigating CAR-T across Academic and Community Settings
Location TBD
This promotional activity is provided by Bristol Myers Squibb and is not certified for continuing education credit.